Loading clinical trials...

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATIONNA

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

Augmenting Cerebral Perfusion With Transcranial Direct Current Stimulation (tDCS) in Chronic Hypoperfusion States

NCT06477107•Mayo Clinic

Summary

This study is being done to examine whether transcranial direct current stimulation (tDCS) will increase cerebral blood flow which may provide a clinical benefit such as improving cognitive impairment.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Vasculopathy leading to imaging evidence of hypoperfusion
•Cognitive impairment

Exclusion Criteria

•Pregnancy
•Contraindication to MRI or tDCS including metallic implanted objects.
•Medical instability or inability to cooperate during the study as assessed by the treating physician to participate in the study.

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

October 24, 2024

Primary Completion Date

June 1, 2026

Completion Date

June 1, 2026

Last Updated

January 20, 2026

Enrollment

ESTIMATED participants

Conditions

Moyamoya SyndromeMoyamoya DiseaseAtheroscleroses, Cerebral

Interventions

Soterix® 4x1HD-TDCS

DEVICE

Soterix® 1x1 tDCS

DEVICE

Cognitive training program

BEHAVIORAL

Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments

NCT07144930

Moyamoya DiseaseHealthy+1 more

View study

RECRUITING

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

NCT05332756

Moyamoya Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

Inclusion Criteria

Exclusion Criteria

Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

Neurosurgical Outcome Network

Carotid Plaque-Burden Scale and Outcomes. A Real Life Study

Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease

Relationship Between Endothelial Progenitor Cells and Revascularization Effect of Moyamoya Disease